Genzyme Corporation v. Cobrek Pharmaceuticals, Inc., et al > Summary
Court Case Number 1:10-cv-00112
Filing Date Jan 7, 2010
Court Illinois Northern District Court
Status Unknown
Plaintiff
Defendant
Plaintiff Attorneys
7Sanofi
Attorney Name: Oscar Alcantara
Goldberg Kohn
Sanofi
Attorney Name: Frederick H. Cohen
Goldberg Kohn
Sanofi
Attorney Name: Fiona E. Darkin
Venable
Sanofi
Attorney Name: Brian D. Fagel Phv
Goldberg Kohn
Sanofi
Attorney Name: Christopher E. Loh
Venable
Sanofi
Attorney Name: Filko Prugo
Venable
Sanofi
Attorney Name: Christina A. Schwarz
Venable
Defendant Attorneys
4Cobrek Pharmaceuticals
Attorney Name: Bruce J. Chasan
Caesar Rivise
Cobrek Pharmaceuticals
Attorney Name: Mona Gupta
Caesar Rivise
Cobrek Pharmaceuticals
Attorney Name: Robert S. Silver
Caesar Rivise
Cobrek Pharmaceuticals
Attorney Name: Robert W. Stevenson
Caesar Rivise
Counter Defendant
3Sanofi
Attorney Name: Oscar Alcantara
Goldberg Kohn
Sanofi
Attorney Name: Frederick H. Cohen
Goldberg Kohn
Sanofi
Attorney Name: Brian D. Fagel Phv
Goldberg Kohn
Counter Claimant
4Cobrek Pharmaceuticals
Attorney Name: Bruce J. Chasan
Caesar Rivise
Cobrek Pharmaceuticals
Attorney Name: Mona Gupta
Caesar Rivise
Cobrek Pharmaceuticals
Attorney Name: Robert S. Silver
Caesar Rivise
Cobrek Pharmaceuticals
Attorney Name: Robert W. Stevenson
Caesar Rivise
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07148211 | Formulation for lipophilic agents | Dec 12, 2006 |
| 05602116 | Method for treating and preventing secondary hyperparathyroidism | Feb 11, 1997 |
